Epigallocatechin-3-gallate (EGCG), a major component in green tea polyphenols, has been proven to suppress colonic tumorigenesis in animal models and epidemiological studies. Since EGCG is retained in the gastrointestinal tract after oral administration, this pharmacokinetics property gives it the potential to function as chemopreventive agent against colon cancer. In this study, human colorectal carcinoma HT-29 cells were treated with EGCG to examine the anti-proliferative and pro-apoptotic effects of EGCG, as well as the molecular mechanism underlying these effects. Cell viability assay, nuclear staining, DNA fragmentation, caspase assay, cytochrome c release, DiOC 6 (3) staining, MAPK phosphorylation and trypan blue exclusion assays, were utilized to dissect the signaling pathways induced by EGCG. After 36 h treatment, EGCG inhibited HT-29 cell growth with IC 50 of about 100 µM. HT-29 cells treated with doses higher than 100 µM showed apparent nuclear condensation and fragmentation, which was confirmed by DNA laddering. Caspase-3 and -9 activation was detected after 12 h treatment, accompanied by mitochondrial transmembrane potential transition and cytochrome c release. Activation of MAPKs was detected as early signaling event elicited by EGCG. Inhibition of JNK pathway showed the involvement of JNK in EGCG-induced cytochrome c release and cell death. EGCG-induced JNK activation was blocked by the antioxidants glutathione (GSH) and N-acetyl-L-cysteine (NAC), suggesting that the cell death signaling was potentially triggered by oxidative stress. In summary, our results from this study suggest that in HT-29 human colon cancer cells (i) EGCG treatment causes damage to mitochondria, and (ii) JNK mediates EGCG-induced apoptotic cell death.
INTRODUCTION
Colon cancer is the second leading source of cancer-derived mortality in the United States [1] . Epidemiological studies have linked the cause of high incidence of colon cancer in Western society to the dietary custom [2] . In Asian countries with relatively lower incidence of colon cancer, such as China, Japan and Korea, one of the prominent life style is the daily consumption of green tea drinks by large population. Chemically, the water-extractable fraction of green tea contains abundant polyphenolic compounds, in which epigallocatechin-3-gallate (EGCG) is the major constituent ( >50% of polyphenolic fraction). After a common brewing procedure, 30-42% (W/W) of green tea can be dissolved in water. Therefore, a single cup of green tea can contain up to 200 mg of EGCG [3] . Cancer prevention effect of green tea and EGCG against various tumors has been proven with numerous animal models [4, 5] . Human clinical trials, although inconclusive, also indicated some positive link between drinking of green tea and the decrease of cancer incidence [6] . In rodent models for determining the pharmacokinetics profile of green tea catechins, the highest tissue concentrations of EGCG have always been found in the intestine after either oral or intravenous administrations [7] [8] [9] . Furthermore, substantial amounts of EGCG were present in human colon mucosa samples from the patients drinking tea 12 h before colorectal surgery [4] . Because of this pharmacokinetics profile, as well as the high local concentration in intestinal microenvironment that come from direct contact of green tea drinks with colon mucosa, the study on potential effectiveness of EGCG on the inhibition of colorectal carcinogenesis has generated great interest. It has been reported that EGCG inhibited azoxymethane (AOM)-induced colon tumorigenesis in the rat [10] , and also drinking green tea blocked the formation of 1,2-dimethylhydrazine-induced colonic aberrant crypt foci (ACF), which is a typical precursor lesion of chemical-initiated colon cancer [11] .
Previous studies have shown that chemoprevention function of EGCG could be attributed to its properties as an antioxidant, phase II enzyme inducer, cell growth inhibitor, or apoptosis inducer [3, [12] [13] [14] [15] [16] . Mechanistic studies of EGCG's inhibitory effect on cell proliferation have demonstrated the regulatory influence of EGCG on the levels and activities of transcription factor AP-1 [17, 18] , NF-κB [19] [20] [21] , cell cycle-related protein p21 [22] , PI3 kinase [23] and mitogen-activated protein kinases (MAPKs) [24, 25] . However, the influence of EGCG on signaling molecules directly involved in apoptotic pathway has not been fully examined. In this study, we compared the antiproliferation effect of EGCG on normal colon epithelial cells and colon carcinoma cells, investigated the morphological changes after EGCG treatments, and determined the influence of EGCG on caspases, cytochrome c, mitochondria, as well as MAPKs. Additionally, through inhibition experiments, we showed that JNK and oxidative stress play important roles in the EGCG-induced apoptosis in HT-29 human colon cancer cells.
MATERIALS AND METHODS

Cell Culture
Human colorectal cancer cells, HT-29, and h uman normal colon epithelial cells, FHC, were purchased from American Type Culture Collection (ATCC). HT-29 cells were maintained in minimum essential medium (MEM) supplemented with 10% fetal bovine serum, 2.2 g/L sodium bicarbonate, 100 U/mL penicillin and 100 µg/mL streptomycin.
Caspase Activity Assay
After treatments, HT-29 cells were washed twice with ice-cold PBS and lysed in a hypotonic buffer containing 50 mM Tris-HCl (pH 7.4), 50 mM β-glycerophosphate, 15 mM MgCl 2 , 15 mM EDTA, 100 µM phenylmethylsulfonyl fluoride (PMSF), 1 mM dithiothrietol (DTT), and 150 µg/ml digitonin. Cell lysates were homogenized by passing through a 23-gauge needle three times. Homogenates were kept on ice for 30 min, and then centrifuged at 12,000 g for 20 min at 4 o C. The supernatants were collected and protein concentrations were determined by the Bradford method (Bio-Rad, CA). The enzymatic activities of caspase-3, caspase-9 and caspase-8, were analyzed by using 200 µM Ac-DEVD-MCA, Ac-LEHD-MCA and Ac-IETD-MCA as fluorogenic substrates, respectively, in assay buffer (100 mM HEPES, 10% sucrose, 10 mM DTT and 0.1% CHAPS). The fluorescence intensity was measured on CytoFluor II fluorescence reader by setting 360 nm as excitation wavelength and 460 nm as emission wavelength.
Preparation of Cytosolic Extracts and Western Blotting Analysis of Cytochrome c Release
HT-29 cells were washed twice with ice-cold PBS and scraped off the plates. Cells were collected by centrifugation at 500 g for 10 min. The cell pellet was resuspended in 500 µL of extraction buffer containing 210 mM mannitol, 70 mM sucrose, 20 mM HEPES-KOH, pH 7.4, 50 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, and protease inhibitors (Complete Cocktail; Roche Molecular Biochemicals, Indianapolis, IN). After incubation on ice for 30 min, cells were homogenized with a glass Dounce and a B pestle. Homogenates were centrifuged at 12,000 g for 5 min at 4°C. Supernatants were collected and further centrifuged at 100,000 g for 30 min at 4°C to yield cytosol. Twenty-five micrograms of total protein, as determined by the Bradford method (Bio-Rad), was resolved on 15% SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride (PVDF) membrane using semi-dry transfer system (Fisher). Membrane was blocked with 5% nonfat dry milk in TBS (20 mM Tris-HCl, 8 g/liter NaCl, pH 7.4) for 1 h at room temperature, followed by incubation with 1 µg/ml primary monoclonal anti-cytochrome c antibody in TBS containing 3% nonfat milk overnight at 4°C. Membrane was washed three times with TBS and blotted with secondary antibody conjugated with horseradish peroxidase (1:10,000 dilution, Jackson ImmunoResearch Laboratories, West Grove, PA) at room temperature for 30 min. The protein was visualized by using ECL TM (Enhanced Chemiluminescence, Amersham, Piscataway, NJ) after washing three times in TBS.
Measurement of Mitochondrial Membrane Potential
After EGCG treatments, HT-29 cells were incubated with 40 nM DiOC 6 (3) for 15 min at 37°C. Then, cells were washed with ice-cold PBS and scraped off the plates in PBS. Cells were collected by centrifugation at 500 g for 10 min and resuspended in 500 µL of PBS containing 2% fetal bovine serum and 40 nM DiOC 6 (3). Fluorescence intensities of DiOC 6 (3) were analyzed on a flow cytometer (FACScan, Becton Dickinson, San Jose, CA) with excitation and emission settings of 484 and 500 nm, respectively. Propidium iodide was added to the sample to gate out dead cells before data collection.
Western Blotting to examine phosphorylation of JNK, ERK and p38
After treatments, HT-29 cells were washed with ice-cold PBS and lysed with 500 µL of lysis buffer (10 mM Tris-HCl, pH 7.4, 50 mM sodium chloride, 30 mM sodium pyrophosphate, 50 mM sodium fluoride, 100 µM sodium orthovandate, 2 mM iodoacetic acid, 5 mM ZnCl 2 , 1 mM phenylmethylsulfonyl fluoride, and 0.5% Triton-X 100). The lysates were homogenized by passing through a 23 G needle three times, and kept in ice for 30 min. The homogenates were centrifuged at 12,000 g for 15 min at 4°C. The protein concentration of whole cell lysates was determined by Bio-Rad protein assay kit. Equal amount of proteins was then resolved on a 10% SDS-polyacrylamide gel and transferred to PVDF membrane using semi-dry transfer system. The membrane was blocked in 5% bovine serum albumin (BSA) solution for 1 h at room temperature, then incubated overnight at 4°C with anti-phospho-MAPK primary antibody (1:1,000 dilution, Cell Signaling Technology, Beverly, MA), which specifically recognized phosphorylated ERK1/2 (Thr202/Tyr204), JNK (Thr183/Tyr185), p38 (Thr180/Tyr182), respectively. After hybridization with primary antibody, membrane was washed with TBS for three times, then incubated with HRP (Horseradish Peroxidase)-conjugated secondary antibody (1:10,000 dilution, Santa Cruz Biotechnology, Santa Cruz, CA) for 30 min at room temperature and washed with TBS three times. Final detection was performed with ECL reagents. 
In Vitro Immunocomplex Kinase Assay for JNK Activity
RESULTS
Antiproliferative Effect of EGCG on Colonic Cells
To assess the inhibitory effect of EGCG on cell growth, human HT-29 colorectal tumor cells and FHC normal colon epithelial cells, were exposed for 36 h to various concentrations of EGCG (from 10 µM to 500 µM), after which cell p roliferation was measured by MTS assay. As shown in Fig. 1 , when treatment concentration was above 50 µM, cell growth in both cell lines was arrested and cytotoxicity of EGCG became apparent. Noticeably, the inhibitory effect of EGCG against cell growth of HT-29 cells was much stronger than that of FHC cells. The effective concentration to inhibit 50% HT-29 cell growth (IC 50 ) was about 100 µM of EGCG. However, IC 50 for FHC was above 250 µM. The reason of this difference between tumor and normal cell lines is not clear at this time, but the selectivity of EGCG against HT-29 cells led to the further study on the mechanism of EGCG-induced cell death in tumor cells. Moreover, interestingly, cell growth was slightly promoted in the low concentration range (10 µM and 25 µM).
EGCG-induced Apoptotic Cell Death in HT-29
To examine the effect of EGCG treatment on cell morphology and identify cell death pathway, HT-29 cells were stained with DAPI nuclear dye. Nuclear fragmentation and condensation implicating apoptotic cell death was increased dose-dependently ( Fig. 2A) , which is consistent with intensified DNA laddering pattern from cells undergoing the same treatments (Fig. 2 B) . Therefore, EGCG induced apoptosis on HT-29 cells in the concentration ranges from 50 µM to 250 µM. Treatments with higher concentrations mostly led to non-specific necrotic cell death.
EGCG-induced Caspase Activities
Since caspases play important roles in dismantling cellular infrastructure during apoptotic events, the influence of EGCG on the caspase activities was examined by using specific fluorogenic substrate for each caspase. First, the activity of caspase-3, which is a converging point of different caspase-dependent apoptosis pathways, was measured after the treatments of different doses of EGCG. As shown in Fig. 3 A, the induction of caspase-3 activity in HT-29 cells was consistent with the results shown in DAPI staining and DNA fragmentation experiments. 100 µM of EGCG led to about 8-fold induction of caspase-3 activity after 24 h treatment. Since the major upstream signal transducers of caspase-3 are death receptor-related caspase-8 and mitochondria damage-related caspase-9, the time-course response from these caspases against 100 µM EGCG treatment were determined to elucidate the caspase-3 activation pathway. As shown in Fig. 3 B, the activation of caspase-3 was initiated around 12 h after treatments, which was relatively delayed comparing to other chemical stress-induced caspase-3 activation. During the 24 h period, the activity of caspase-8 in HT-29 cells was unchanged, but the activity of caspase-9 was consistently increased. This implied the possible involvement of mitochondrial damage in EGCG-induced apoptosis.
EGCG-induced Cytochrome c Release and Mitochondrial Membrane Potential Change
To examine the possible role of mitochondria in the apoptotic death of HT-29 cells induced by EGCG, the existence of cytochrome c in cytosolic fraction of cell lysis was measured after EGCG treatments. As shown in Fig. 4A , the release of cytochrome c from mitochondria was time-and dose-dependent. 12 h of 100 µM EGCG treatment led to dramatically increased amount of cytochrome c leaking from mitochondrial membrane to cytosol in HT-29 cells. The influence of EGCG on mitochondrial membrane integrity was also measured by DiOC 6 (3) dye staining (Fig. 4 B) , which showed the decreased membrane potential ( ∆ψ m ) caused by the mitochondrial membrane permeability transition after EGCG treatments.
EGCG-induced MAPK Activation
The activation of caspases and the release of cytochrome c from mitochondria in HT-29 cells were only observed after 6-12 h of 100 µM EGCG treatments. In order to identify some early signaling events induced by EGCG in HT-29 cells, the responses of mitogenactivated protein kinases (MAPKs), which are a group of important signaling molecules sensitive and responsive to extracellular stimuli, were measured. As shown in Fig. 5A , all of the three major MAPKs, JNK, ERK and p38, were phosphorylated and activated timedependently in HT-29 cells after EGCG treatments. The activation of MAPKs was observed starting about 5 -15 min, and peaking around 1 h. Additionally, the result obtained from the phosphorylation of JNK protein was corroborated by using in vitro kinase assay with GST-c-Jun as substrate. Moreover, the activation of these MAPKs was dose-dependent (Fig. 5B) . Comparing the EGCG concentrations for the activation of JNK and p38, the activation of ERK was initiated with relatively lower concentration (about 10 µM).
Role of JNK and ERK in EGCG-induced cell death
The immediate and potent activation of JNK pathway led to the interest on the possible function of JNK in initiating apoptotic signals in HT-29 cells. A newly-discovered JNK inhibitor, SP600125, was adopted to block this pathway [26] . As shown in Fig. 6 A, pretreatment of SP600125 can dramatically decrease JNK kinase activities and the phosphorylation of JNK1 and JNK2 induced by 1 h treatment of 100 µM EGCG. Interestingly, the decrease of JNK activation was accompanied with t he simultaneously increased ERK activation, especially in the pretreatment of the cells with 25 µM SP600125. To elucidate the influence of inhibiting early JNK activation on late-stage cell death events, cytosolic level of cytochrome c protein after 12 h EGCG treatment was also examined. SP600125 pretreatment led to the decreased release of cytochrome c from mitochondrial membrane after EGCG treatment, which was consistent with the lower percentage of cell death in HT-29 samples co-treated with EGCG and SP600125, as compared to the cells treated only with EGCG (Fig. 6 A) . Next, the role of ERK in EGCG-induced apoptosis was examined by using PD98059, a potent ERK inhibitor. As shown in Fig. 6 B, pretreatment of PD98059 not only eliminated EGCG-induced ERK activation, but also abolished the basal level of activated ERK in HT-29 cells. At the same time, the phosphorylation of JNK was slightly increased in the co-treatment of 50 µM PD98059 and 100 µM EGCG. Cytochrome c release assay showed that PD98059 did not independently cause damage to mitochondria, but it robustly raised the release of cytochrome c induced by EGCG treatment (Fig. 6 B) . Cell death assay indicated that, comparing to respective controls, cell death was increased after PD98059 treatment alone as well as co-treatment with EGCG (Fig. 6B) . In contrast, SB203580, a p38 pathway inhibitor, had no major effect on cytochrome c release or cell death induced by EGCG (data not shown).
Role of Oxidative Stress in EGCG-induced Cell Death
EGCG not only can function as an antioxidant, but it possesses the chemical property of pro-oxidant. To test whether the generation of the apoptotic signals was related to oxidative stress after EGCG treatments, HT-29 cells were pretreated with major intracellular antioxidants, reduced glutathione (GSH) and N -acetyl-L-cysteine (NAC). As shown in Fig. 7 , the activation of JNK or ERK was eliminated by the GSH and NAC pretreatments, which was followed by the abolishment of cytochrome c release. Also, cell death induced by EGCG in H T-29 cells was dramatically inhibited (Fig. 7) . These results indicated that oxidative stress is involved in EGCG-induced cell death. It has been shown that EGCG may induce the production of hydrogen peroxide (H 2 O 2 ) in the culture media, which may be linked to the cytotoxic effect of chemical treatments [27, 28] . To identify whether the source of oxidative stress caused by EGCG in HT-29 cells is via the generation of H 2 O 2 , catalase, which catalyze H 2 O 2 to water and oxygen, was added to the media before EGCG treatment. Surprisingly, the pretreatment of catalase did not block the activation of JNK and ERK induced by EGCG, but had clear inhibitory effect on H 2 O 2 treatment (Fig. 8 A) . Examining the cell morphology under the microscope, the apparent protective effect from catalase can only be observed against H 2 O 2 treatment, but not against EGCG treatment (Fig. 8B) .
DISCUSSION
Cancer chemoprevention is conducted through the administration of chemical or dietary components to interfere with the initiation, promotion and progression of tumors. According to Report of the Chemoprevention Working Group to the American Association of Cancer Research in 1999, one of the major strategies adopted in chemoprevention is to suppress the carcinogenic process after initiation [29] . In this study, EGCG elicited the strong pro-apoptotic effect on carcinoma cells, and affected the proliferation of normal and tumor colon cells distinctively. The selectivity of cytotoxicity against cancerous cells is c onsistent with previous report that showed EGCG had a pronounced growth inhibitory effect on SV40 virally transformed WI38 human fibroblasts but not on their normal counterparts [30] . This observation infers that EGCG has the potential to function as a suppressing agent against the promotion and progression of adenoma and carcinoma cells. In comparison to other carcinoma cell lines, HT-29 is not the most sensitive cell line to EGCG treatments with respect to the growth inhibition and the induction of cell death [4] . The reason for this observation may partially be attributed to the fact that EGCG is extensively metabolized to methylated and glucuronidated conjugates in HT-29 cells, and then actively pumped out of cells by multidrug resistance-related proteins (MRPs) as shown in recent study about the uptake, biotransformation, and efflux of EGCG in HT-29 cells [31] . Furthermore, 100 µM concentration of EGCG adopted in this study is within the range of EGCG concentration in the normal green tea beverage, which may reach up to 300 µM as calculated from the fact that a single cup of green tea drink may contain 150-200 mg EGCG [32, 33] .
Caspase-3, -8 and -9, which are members of the protease family, function as initiators and effectors in the apoptosis process. After proteolytic activation from procasapases, activated caspases can recognize the tetrapeptide motif in target proteins and specifically cleave the peptide chain after aspartic acid, which then leads to deregulation of protein activities and dismantling of the cytoskeletal and cellular structure [34] . The activation of caspase-3 has been shown in human chondrosarcoma and cervical cancer cells treated with EGCG [25, 35] . It has been reported that EGCG can directly bind to Fas death receptor to initiate the caspase-8 activation and apoptosis [36] . However, caspase-8 activity in HT-29 cells remained unchanged after EGCG treatments. Contrasting to caspase-8, the activity of caspase-9 in HT-29 cells had the similar induction pattern as caspase-3 activity after EGCG treatments. Therefore, it implied the involvement of mitochondrial damage in EGCG-induced apoptosis. This is the first report to show that EGCG can induce cytochrome c release and mitochondria membrane permeability transition. These observations are consistent with the previous report that EGCG can lead to the decrease of anti-apoptotic Bcl-2 and Bcl-X(L) proteins and the increase of pro-apoptotic Bax proteins [37] .
The activation and initiation of direct apoptotic signaling is quite delayed in EGCG-treated HT-29 cells, as compared to the apoptotic events induced by Fas ligands or chemicals that specifically target to mitochondria. In this study, we observed the early response from HT-29 cells through measuring the changes on MAPKs, among which JNK1/JNK2 and p38, are connected to stress-activated apoptosis, and ERK1/ERK2 are linked to cell proliferation and survival [38] . After EGCG treatments, the phosphorylation of JNKs, ERKs and p38 are pronounced with minor differences in the extent and the kinetics of activation. This phenomenon is consistent with our previous observation on HeLa and HepG2 cells treated with green tea polyphenols [24, 25] , as well as the results in some recent reports about the effect of EGCG in breast cancer cells, macrophages, and keratinocytes [39] [40] [41] , but it is opposite to the conclusions with other publications, which showed the inhibitory effect of EGCG on the activation of MAPKs [42, 43] . The reason for this discrepancy is unclear, but may be attributed to the experimental designs as well as cell lines.
Recent studies by using t arget gene disruption have established that JNK signaling pathway is required for stress-induced release of mitochondrial cytochrome c and apoptosis [44] . The intermediate signaling moiety between JNK activation and cytochrome c release may be linked to Bax protein, since activated JNK fails to induced apoptosis in cells deficient of members of the proapoptotic Bax subfamily of Bcl2-related proteins; as well as in JNK-deficient cells, stress signals fail to activate Bax, induce cytochrome c release, and cause cell death [45] . In our present study, pretreatments of SP600125, a specific blocker for JNK pathway through reversible ATP-competitive inhibition, led to substantial decrease of cytochrome c release and cell death in response to EGCG treatment. This suggests that JNK pathway may play a pivotal role in EGCGinduced cell death. With regard to ERK pathway, noticeably, relatively lower EGCG concentrations were needed for ERK activation, as compared to the concentrations for JNK and p38. This was consistent with the slight increment of cell proliferation in the treatments with 10 and 25 µM EGCG. Also, the application of PD98095 dramatically intensified the damage to HT-29 cells caused by EGCG. Both events highlighted the positive function of ERKs in cell proliferation and survival. The simultaneous sustained activation of all three major MAPKs, which have different and in some case opposite biological function, indicates that the balance and integration of MAPK pathways may modulate the commitment of cells to apoptosis or survival following external stimuli [46, 47] . In our study, co-treatments of JNK inhibitor and EGCG led to an increased ERK activation. Furthermore, ERK inhibitor and EGCG led to the increased JNK activation. This indicates that the cross-talk exists between these two pathways. It has been shown that there are extensive interactions among the upstream kinases of all three MAPKs [38] . Future investigation about the influence of E GCG on these upstream elements will shed light on how those MAPKs are activated and how EGCG-initiated chemical signals are converted to apoptotic response.
Among all of green tea phenolic compounds, EGCG is the most potent in regard to the bioactivity, and EGCG also contains the most hydroxyl groups in the structure. The studies on antioxidative property of EGCG have shown the trapping effect on reactive oxygen species (ROS) and the inhibitory effect on lipid peroxidation [48] . However, after neutralizing peroxyl and other radicals, EGCG itself can be converted to phenoxyl radical [49] . Also, in normal physiological pH condition, EGCG may undergo autooxidation to form dimers, accompanying with the generation of ROS [31, 50] . In this study, the chemical property of EGCG as potential pro-oxidant was highlighted by the blocking effect of GSH and NAC against EGCG-induced MAPK activation, cytochrome c release and cell death. It has been shown that EGCG may induce the production of hydrogen peroxide (H 2 O 2 ) in the culture media [27, 28] . However, pretreatment of catalase in this study failed to diminish EGCG-induced MAPK activation and apoptosis in HT-29 cells. This observation is consistent with previous report that the inhibition of β-catenin expression by EGCG was irrelevant with the generation of H 2 O 2 [51] . Further studies are required to examine whether other oxidizing radicals are involved in the initiation of stress signals from EGCG.
In conclusion, in this study, we examined the molecular mechanism of EGCGinduced apoptosis on HT-29 human colon adenocarcinoma cell line. EGCG treatments induce oxidative stress, thereafter activate stress signals, such as JNK pathway, which lead to the changes on mitochondrial membrane permeability and the release of cytochrome c. Subsequently, casapse-9 and caspase-3 are activated, followed by DNA fragmentation and nuclear condensation. Collectively, these results imply that the proapoptotic effect of EGCG may in part contribute to its overall chemopreventive function against colonic carcinogenesis. 
